PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-Oct-2023 Oxford BioDynamics Receives Reimbursement Code for EpiSwitch® Prostate Screening (PSE) Test Businesswire
03-Oct-2023 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
03-Oct-2023 Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting Businesswire
03-Oct-2023 Takeda提供關於EXKIVITY® (mobocertinib)的最新資訊 Businesswire
03-Oct-2023 Takeda提供关于EXKIVITY® (mobocertinib)的更新信息 Businesswire
03-Oct-2023 Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows Businesswire
03-Oct-2023 Flightpath Biosciences and the Forsyth Institute Enter Into Co-Development Agreement Targeting Oral Disease Newswire
03-Oct-2023 The Immunoglobulin National Society and ACHC Announce Partnership Newswire
03-Oct-2023 HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 Newswire
03-Oct-2023 Introducing the ONI Discovery Kit (TM): dSTORM in Cells Newswire
03-Oct-2023 RWS Establishes Presence in Africa Businesswire
03-Oct-2023 Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering Businesswire
03-Oct-2023 Takeda fait le point sur EXKIVITY® (mobocertinib) Businesswire
03-Oct-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-Oct-2023 Qkine Appoints Industry-leading CliniSciences as New European Distributor for Their Growth Factor and Cytokine Portfolio Businesswire
03-Oct-2023 For the First Time, Researchers Successfully Demonstrate Over euNetworks’ Fibre Infrastructure That Quantum Communication Is Possible Between the United Kingdom and Ireland Businesswire
03-Oct-2023 Ganymed Robotics Announces Appointment of Seasoned Leadership Team to Bring to Market Its Next Generation Surgical Technology Businesswire
03-Oct-2023 Takeda Fornece Atualização sobre EXKIVITY® (mobocertinib) Businesswire
03-Oct-2023 President of The Physiological Society congratulates 2023 Nobel Prize winner The Physiological Society
03-Oct-2023 Takeda gibt Update zu EXKIVITY® (Mobocertinib) Businesswire